Dr Bethany M Hays, MD in Falmouth, ME - Obstetrics & Gynecology

Dr Bethany M Hays, MD is a Obstetrics & Gynecology physician based in Falmouth, Maine. Dr Bethany M Hays is licensed to practice in Maine (license number 013291) and her current practice location is 202 Us Route 1, Suite 200, Falmouth, Maine. She can be reached at her office (for appointments etc.) via phone at (207) 781-4488.

NPI number for Dr Bethany M Hays is 1710034749 and her current mailing address is 202 Us Route 1, Suite 200, Falmouth, Maine. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1710034749.

Contact Information

	Dr Bethany M Hays, MD
	202 Us Route 1, Suite 200, Falmouth, ME 04105-1327
	(207) 781-4488
	(207) 781-4470

Physician's Profile

Full Name	Dr Bethany M Hays
Gender	Female
Speciality	Obstetrics & Gynecology
Location	202 Us Route 1, Falmouth, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1710034749
Provider Enumeration Date: 01/04/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Bethany M Hays such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1710034749	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	013291 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Bethany M Hays is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Bethany M Hays, MD 202 Us Route 1, Suite 200, Falmouth, ME 04105-1327 Ph: (207) 781-4488	Dr Bethany M Hays, MD 202 Us Route 1, Suite 200, Falmouth, ME 04105-1327 Ph: (207) 781-4488

News Archive

NCCN Guidelines: Chemosensitivity/resistance assays to be part of Principles of Chemotherapy section

Precision Therapeutics announced today that The National Comprehensive Cancer Network® recently updated the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section.

Gentium S.p.A. updates on phase 3 trial of Defibrotide for severe veno-occlusive disease

Gentium S.p.A. announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of Defibrotide for Severe Veno-Occlusive Disease (VOD).

Saskatchewan nursing homes to test improvement program to increase patient care time in hospitals

Three Saskatchewan nursing homes will be the first long-term care facilities to test the effectiveness of an improvement program that has been shown to increase the amount of time providers spend on direct patient care in hospitals.

Study: More investment is needed to produce, distribute approved COVID-19 vaccines

The success of a COVID-19 vaccine will depend not only on its efficacy but will hinge at least as much on how fast and widely it can be delivered, the severity of the pandemic, and the public's willingness to be immunized, according to a study published in Health Affairs.

Dr Bethany M Hays, MD - Obstetrics & Gynecology in Falmouth, ME